Log in or Sign up for Free to view tailored content for your specialty!
Infection News
Patients with gout may be at higher risk for severe COVID-19 even after vaccination
Patients with gout, and especially women, may be at higher risk for SARS-CoV-2 infection and severe outcomes regardless of vaccination status, according to data published in Arthritis & Rheumatology.
Highlights from ACR Convergence 2022
In this episode of Meeting Mic, we bring you the highlights and insights from the ACR Convergence 2022, as well as Healio’s top headlines from the meeting.
Log in or Sign up for Free to view tailored content for your specialty!
A familiar fight against an unfamiliar foe: Rheumatologists brace for long COVID’s impact
In an interview with “60 Minutes” that aired on Sept. 18, President Joe Biden declared, “The pandemic is over.” And in some ways, he was correct.
Women with lupus demonstrate low HPV vaccination rates, high infection rates
PHILADELPHIA — Among women with systemic lupus erythematosus, just 3.7% are vaccinated for HPV, while nearly 30% demonstrate HPV infection, according to data presented at ACR Convergence 2022.
Unvaccinated pregnant patients with RMDs, COVID-19 at higher risk for preterm birth
PHILADELPHIA — Preterm birth is more frequent among unvaccinated pregnant patients with rheumatic and musculoskeletal diseases and COVID-19 vs. fully vaccinated patients, according to findings presented at ACR Convergence 2022.
Ten-day MMF hiatus after COVID-19 vaccine doses boosts antibody response
PHILADELPHIA — Withholding mycophenolate mofetil for at least 10 days following two doses of the COVID-19 vaccine significantly increased antibody response without greatly increasing the rate for flares, according to data presented here.
ACR: Varicella vaccine strongly recommended in all immunosuppressed adults
PHILADELPHIA — The varicella vaccine is strongly recommended in all adults aged 18 years or older who are immunosuppressed, according to presenters at ACR Convergence 2022.
Evolving COVID-19 variants limit effectiveness of current therapies
PHILADELPHIA — Outpatient therapies for COVID-19 are largely being limited by evolving variants’ ability to evade effectiveness, and remaining therapies require careful management, according to a speaker at ACR Convergence 2022.
Understanding of long COVID shifting at ‘breakneck speed’
PHILADELPHIA — The understanding of long COVID, its symptoms and even its definition, continues to rapidly change amid a flood of data, according to Leonard H. Calabrese, DO, and Alfred Kim, MD, PhD, at ACR Convergence 2022.
ACR Keynote: Camus’ ‘The Plague’ predicted ‘every part’ of COVID-19 pandemic
PHILADELPHIA — Looking not only to history, but also to narratives like novels and movies, can help health care professionals understand and move beyond the COVID-19 pandemic, according to the keynote speaker at ACR Convergence 2022.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read